Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy begins with a low introductory dose that increases every four weeks over 16 weeks to reach maintenance levels. This gradual approach helps your body acclimate to the medication while allowing your prescriber to monitor your individual response and tolerance. Understanding how starting doses work empowers you to make informed decisions about your weight loss treatment plan.
How Semaglutide Starting Doses Are Structured
Semaglutide therapy typically initiates at 0.25 mg once weekly, a dose intentionally chosen to be subtherapeutic—meaning it's below the level that produces maximum weight loss effects. This conservative starting point allows your gastrointestinal system and metabolic pathways to adapt gradually. Over the following three months, most patients progress through four escalating dose levels before reaching their therapeutic maintenance dose. This titration schedule reflects decades of clinical trial data showing that slower dose increases improve tolerability and long-term adherence.
The standard dose escalation follows a predictable pattern: week one begins at 0.25 mg, week five increases to 0.5 mg, week nine moves to 1.0 mg, and week thirteen reaches 1.7 mg or higher depending on individual response. Some patients benefit from extending this timeline or pausing at intermediate doses if they experience significant gastrointestinal symptoms. Your prescriber may customize your specific progression based on how your body responds at each stage.
Why Lower Starting Doses Reduce Side Effects
Beginning semaglutide therapy at a low dose gives your body time to develop tolerance to the medication's effects on appetite signaling and gastric emptying. When patients start too high, they often experience nausea, vomiting, and constipation severe enough to discontinue treatment prematurely. Clinical research demonstrates that gradual titration improves treatment completion rates and patient satisfaction compared to higher initial dosing strategies.
Your individual genetics influence how quickly your body adapts to GLP-1 activation. The PlexusDx Precision Peptide Genetic Test examines key variants in your GLP1R and GIPR pathways—the primary receptors responsible for semaglutide's effects—to identify whether your biology may benefit from a customized dosing timeline. Patients with certain genetic predispositions toward heightened GLP-1 sensitivity may progress more slowly through dose escalations while still achieving excellent outcomes.
Compounded Semaglutide vs. Brand-Name Ozempic Dosing
Compounded semaglutide from licensed 503A pharmacies delivers the same active pharmaceutical ingredient as brand-name Ozempic, following identical dosing protocols and titration schedules. The primary difference lies in cost and accessibility: PlexusDx compounded semaglutide injections start at $149 per month regardless of your dose level, eliminating the financial barriers that prevent many patients from accessing this effective therapy. Both formulations require the same gradual dose escalation, the same weekly injection frequency, and the same medical oversight.
PlexusDx serves all 50 states without requiring insurance coverage, health insurance membership, or monthly fees. Your dose may increase as you progress through treatment. Your price won't. This pricing structure ensures that patients at every stage of their weight loss journey receive consistent affordability, whether they're beginning at 0.25 mg or maintaining at higher therapeutic levels.
Personalizing Your Semaglutide Treatment Journey
While standard dosing protocols guide most patients, your individual biology creates unique opportunities for optimization. The PlexusDx approach combines your starting dose recommendations with genetic insights mapping 14 metabolic pathways, 49 peptides, and 150+ genetic markers related to weight regulation. Understanding your FTO, MC4R, GIPR, and GLP1R variants helps your prescriber anticipate your likely response trajectory and adjust timing accordingly.
HSA and FSA accounts cover PlexusDx compounded semaglutide, and patients can add the Precision Peptide Genetic Test for $99 after starting their first month of treatment. This optional genetic assessment reveals whether your genetics suggest faster progression, extended titration, or potential responsiveness markers that inform your complete personalization strategy. Your prescriber uses these insights alongside your clinical presentation to optimize your starting dose timeline and maintenance targets.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the standard starting dose of semaglutide for weight loss?
Semaglutide therapy begins at 0.25 mg once weekly, increased progressively every four weeks to reach therapeutic maintenance doses. This gradual titration schedule minimizes gastrointestinal side effects while allowing your body to adapt. PlexusDx compounded semaglutide follows this same evidence-based dosing protocol starting at $149 per month.
How long does it take to reach the full therapeutic dose?
Most patients complete the standard 16-week titration schedule, reaching maintenance doses of 1.7 mg to 2.4 mg by week 13. Some individuals benefit from extended timelines if they experience significant side effects at intermediate steps. Your prescriber adjusts your personal progression based on your tolerance and clinical response.
Is compounded semaglutide as effective as brand-name Ozempic?
Compounded semaglutide from licensed 503A pharmacies contains the identical active pharmaceutical ingredient as Ozempic, manufactured under strict quality standards. The weight loss outcomes, dosing protocols, and safety profiles are equivalent. PlexusDx compounded semaglutide offers the same effectiveness at significantly lower cost—starting at $149 monthly.
What side effects should I expect when starting semaglutide?
Early side effects typically include mild nausea, reduced appetite, and occasional constipation, which diminish as your body adapts during the titration phase. Starting at the low 0.25 mg dose significantly reduces the severity of these effects. Severe or persistent symptoms should be reported to your prescriber immediately for dose-timing adjustments.
How does genetic testing influence my starting dose strategy?
The PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R, GIPR, FTO, and MC4R genes that predict how your body may respond to semaglutide titration. Certain genetic patterns suggest you may progress faster, require slower escalation, or experience heightened sensitivity—information your prescriber uses to customize your timeline. This optional $99 test adds personalization after your first treatment month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Journey: Should You Take Mounjaro on a Full Stomach?
Navigating Your Journey: How to Confidently Travel with Your Ozempic Pen